Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria

Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen

Genzyme Reports Strong Second-Quarter Growth

Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases

Genzyme and Isis Complete Licensing of Mipomersen

Genzyme Files Applications for Approval of Mozobil in the United States and Europe

Genzyme Boosts Quality Using Dyadem Quality Lifecycle Management

Seven Summits Research Releases Alerts on INTC, DIS, NMX, GENZ, and DFS

Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients

Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction

Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, HealthShares(TM) Dermatology and Wound Care Index and HealthShares(TM) Orthopedic Repair Index

Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease

FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen

Genzyme Reports Strong First-Quarter Growth

Genzyme to Build New R&D Center in Beijing

Genzyme Provides Update on Myozyme(R) Manufacturing

Seven Summits Research Releases Alerts on RIMM, C, MA, JOYG, and GENZ

Aggressive Stock Alert: MIHS! April 15, 2008

Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy

BellwetherReport.com Free Analyst Review for AAPL, ZION, KLAC and GENZ